We are live on ! Find out more
BLC

Brown, Lisle/Cummings Portfolio holdings

AUM $400M
1-Year Est. Return 18.79%
This Fund
S&P 500
This Quarter Est. Return
+9.1%
1 Year Est. Return
+18.79%
3 Year Est. Return
+61.76%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$294M
AUM Growth
+$24.8M
Cap. Flow
+$3.73M
Cap. Flow %
1.27%
Top 10 Hldgs %
27.5%
Holding
581
New
10
Increased
91
Reduced
72
Closed
23

Top Buys

Rank Stock Value
1
VRT icon
Vertiv
VRT
+$649K
2
SPYI icon
NEOS S&P 500 High Income ETF
SPYI
+$575K
3
IWM icon
iShares Russell 2000 ETF
IWM
+$364K
4
ARCC icon
Ares Capital
ARCC
+$301K
5
RTX icon
RTX Corp
RTX
+$295K

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$222K
2
BUD icon
AB InBev
BUD
+$161K
3
DXC icon
DXC Technology
DXC
+$155K
4
RIO icon
Rio Tinto
RIO
+$149K
5
VZ icon
Verizon
VZ
+$144K

Sector Composition

Rank Sector Weight
1 Healthcare 17.78%
2 Technology 16.36%
3 Financials 13.85%
4 Industrials 9.58%
5 Communication Services 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PJT icon
551
PJT Partners
PJT
$4.45B
$283 ﹤0.01%
3
– –
AVNS
552
DELISTED
Avanos Medical
AVNS
$219 ﹤0.01%
11
– –
ALLK
553
DELISTED
Allakos
ALLK
$189 ﹤0.01%
150
– –
BHF icon
554
Brighthouse Financial
BHF
$3.55B
$103 ﹤0.01%
2
– –
CGC
555
Canopy Growth
CGC
$393M
$86 ﹤0.01%
10
– –
FG icon
556
F&G Annuities & Life
FG
$3.93B
$81 ﹤0.01%
2
– –
NOK icon
557
Nokia
NOK
$53.5B
$14 ﹤0.01%
+4
New +$14
AQB icon
558
AquaBounty Technologies
AQB
$5.1M
$2 ﹤0.01%
1
– –
ABUS icon
559
Arbutus Biopharma
ABUS
$913M
– –
-7,500
Closed -$18.8K
BDJ icon
560
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.74B
– –
-662
Closed -$5.09K
DCI icon
561
Donaldson
DCI
$11.3B
– –
-125
Closed -$8.17K
DTM icon
562
DT Midstream
DTM
$13.6B
– –
-166
Closed -$9.1K
EMF
563
Templeton Emerging Markets Fund
EMF
$328M
– –
-560
Closed -$6.54K
FGD icon
564
First Trust Dow Jones Global Select Dividend Index Fund
FGD
$1.58B
– –
-105
Closed -$2.34K
GRC icon
565
Gorman-Rupp
GRC
$2.25B
– –
-200
Closed -$7.11K
HBAN icon
566
Huntington Bancshares
HBAN
$35.6B
– –
-1,000
Closed -$12.7K
INO icon
567
Inovio Pharmaceuticals
INO
$70M
– –
-1
Closed -$4
KEY icon
568
KeyCorp
KEY
$24.8B
– –
-750
Closed -$10.8K
KMT icon
569
Kennametal
KMT
$2.6B
– –
-175
Closed -$4.51K
KRE icon
570
State Street SPDR S&P Regional Banking ETF
KRE
$4.71B
– –
-900
Closed -$47.2K
MGA icon
571
Magna International
MGA
$19.2B
– –
-173
Closed -$10.2K
MPT
572
Medical Properties Trust
MPT
$2.79B
– –
-2,500
Closed -$12.3K
SNOW icon
573
Snowflake
SNOW
$110B
– –
-600
Closed -$119K
TFC icon
574
Truist Financial
TFC
$64.6B
– –
-350
Closed -$12.9K
TROX icon
575
Tronox
TROX
$933M
– –
-200
Closed -$2.83K
20 21 22
23
24

Similar funds

JGCM
Joseph Group Capital Management Columbus, Ohio $400M AUM 18.42% 1-Year Est. Return
AIM
Alpine Investment Management Hong Kong $401M AUM 17.09% 1-Year Est. Return
SFCL
Strengthening Families & Communities LLC Boston, Massachusetts $401M AUM 33.17% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $401M AUM 284.76% 1-Year Est. Return
DBIA
Dumont & Blake Investment Advisors Princeton, New Jersey $400M AUM 21.87% 1-Year Est. Return
KHCM
Kettle Hill Capital Management New York $399M AUM 10.05% 1-Year Est. Return
IAA
Ironsides Asset Advisors Rocky Mount, North Carolina $399M AUM 13.99% 1-Year Est. Return
T2I
Turim 21 Investimentos Rio De Janeiro, Brazil $399M AUM 20.13% 1-Year Est. Return

Brown, Lisle/Cummings's Q1 2024 Portfolio in Review

As of Q1 2024, Brown, Lisle/Cummings held 581 positions worth $294M, up 9.2% from $270M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Brown, Lisle/Cummings's Q1 2024 filing shows 10 new, 91 increased, 72 reduced and 23 closed positions. Its largest new stake was Vertiv: 10,325 shares worth $843K. The largest sale was GSK, an estimated $222K.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

  • Brown, Lisle/Cummings's largest Q1 2024 buy was Vertiv: 10,325 shares worth $843K.
  • Brown, Lisle/Cummings added most to NEOS S&P 500 High Income ETF in Q1 2024, an estimated $575K increase.
  • Brown, Lisle/Cummings's biggest Q1 2024 reduction was GSK, cutting an estimated $222K.
  • Brown, Lisle/Cummings fully exited Snowflake in Q1 2024, selling an estimated $119K.
  • Brown, Lisle/Cummings's ten largest holdings make up 27% of its $294M portfolio in Q1 2024.
  • Brown, Lisle/Cummings opened 10 new positions and closed 23 in Q1 2024.
  • Brown, Lisle/Cummings's portfolio value rose 9.2% quarter-over-quarter to $294M.

Based on Brown, Lisle/Cummings's 13F filing for Q1 2024, filed 1 Jul 2024.